ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

DeVita Heads U.S. Board Of CCCR

August 4, 1989

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

In Brief: Margaret Sloan, Pioneer In International Medicine Collaboration, Dies; Hammer To Address AACI

January 1, 1982

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

Guest Editorial – Interlocking Tragedies: Lance Armstrong and CPRIT

February 15, 2013

Charges Against CC Probed; Most Found Invalid

March 31, 1978